Robbins Essential Pathology Hematopoietic and Lymphoid Systems PDF

Summary

This document is a section from a medical textbook on pathology, focusing on the hematopoietic and lymphoid systems. It covers topics such as red blood cell disorders and anemias. The detailed nature of the text suggests it's suitable primarily for advanced students or researchers in the medical field.

Full Transcript

9 H...

9 Hematopoietic and Lymphoid Systems O U T L I N E Red Blood Cell Disorders, 137 Non-Hodgkin Lymphomas and Chronic Lymphoid Leukemias, 151 Anemias, 137 Hodgkin Lymphoma, 156 Hemolytic Anemias, 137 Plasma Cell Neoplasms and Related Entities, 157 Underproduction Anemias, 143 Histiocytic Neoplasms, 158 White Blood Cell Disorders, 146 Bleeding Disorders, 158 Nonneoplastic Disorders of White Cells, 146 Thrombocytopenia, 159 Leukopenia, 146 Coagulation Disorders, 160 Reactive Leukocytosis, 146 Disorders of Spleen and Thymus, 162 Neoplastic Proliferations of White Cells, 147 Splenomegaly, 162 Acute Leukemias, 148 Disorders of the Thymus, 162 Myelodysplastic Syndromes, 150 Thymic Follicular Hyperplasia, 162 Myeloproliferative Neoplasms, 150 Thymoma, 162 he emaopoec and ympod sysems are afeced by a wde spec- o ssues. Oer clncal consequences o anema are deermned by s rum o dseases, wc can be subdvded based on weer ey pr- severy, rapdy o onse, and underlyng paogenc mecansm, and marly afec red cells, we cells, or e emosac sysem (plaeles wll be dscussed under e specc enes a ollow. and coagulaon acors). We wll organze our dscusson accordngly, recognzng a dsorders a prmarly afec one componen o e Hemolytic Anemias emaolympod sysem oten secondary mpac oers. In addon, Hemo ly tic a nemia s a re a d iv ers e g ro u p of di s o r d e r s that h av e we w brely dscuss dsorders o e speen and (because o er nk as a co mmo n fea ture a ccel era t ed re d cell d e s t r u c t i o n ( h e m o l y s i s ) o ceran mmunoogc dsorders) dsorders o e ymus. he red ce e span s sorened beow s norma 120 days, eadng o anema and aendan ssue ypoxa. Oxygen-sensng ces n e kdney respond by ncreasng e producon o er y- ropoen, smuang e proeraon o marrow er yrod ee- RED BLOOD CELL DISORDERS mens and ncreasng red ce producon. hus, yperpasa o marrow er yrod precursors and ncreased numbers o newy reeased ANEMIAS red ces (retcuocytes) n e bood are amarks o emoyc anemas. Anemia, one of the most common disorders of humans, is a state of red Pathogeness. Mos emoyc anemas are caused by nrnsc red ce cell deciency that lowers the oxygen-carrying capacity of the blood. deecs or damage nduced by exrnsc acors a ncrease red ce Anema may resu rom bood oss, ncreased red ce desrucon desrucon by pagocyes, parcuary n e speen. B ecause e red (emoyss), or decreased red ce producon. Hemoyc anemas can ces are removed rom e crcuaon by pagocyes, s s reerred be urer subcassed based on weer ey are caused by deecs o as extravascuar emoyss. Fndngs a are reavey specc or a are nrnsc or exrnsc o e red cell. hese mecansms provde exravascular emolyss nclude e ollowng: one bass or cassyng anemas (Tabe 9.1).    Hyperbrubnema and jaundce, due o degradaon o emoglo- bn n macropages Clncal Features. Careu assessmen o red ce morpoog y and    Spenomegay due o “work yperplasa” o pagocyes n e spleen red ce ndces eps o narrow e dagnosc possbes. he mean    Brubn-rc gastones (pgmen sones), because blrubn s a ce voume (MCV; e average voume per red ce) dsnguses e breakdown produc o emoglobn, and an ncreased rsk o cole- mcrocyc (ow MCV), normocyc (norma MCV), and macrocyc cyss secondar y o ble duc obsrucon (g MCV) anemas, wc ypcay ave dsnc causes (Tabe 9.2). In soaed anema, perpera bood ess usuay suice o esabs e Intravascuar emoyss s caused by njures a are so severe a cause. Wen anema occurs n concer w rombocyopena and/or red cells burs wn e crculaon. hese may be caused by mecan- granuocyopena, a marrow dsorder (e.g., apasa or nlraon by a ca orces (e.g., urbuen bood low) or bocemca or pysca agens neoplasm) s lkely and a bone marrow examnaon s oten warraned. a damage e red ce membrane. Fndngs a dsngus nravas- Paor, ague, and assude are common o a orms o anema. I e cuar emoyss rom exravascuar emoyss ncude: onse s sow, e dec n oxygen-carryng capacy s parally compen-    Hemogobnema and emogobnura. Hemogobn reeased no saed or by adapve ncreases n plasma volume, cardac oupu, resp- e crcuaon passes no e urnar y space and s oxdzed o raory rae, and oer meabolc canges a ncrease oxygen delvery meemogobun, eadng o browns dscooraon o e urne. 137 138 CHAPTER 9 Hematopoietic and Lymphoid Systems Table 9.1 Classification of Anemia According to Underlying Mechanism Blood Loss Acute Trauma Chronic Gastrointestinal tract lesions, gynecologic disturbances Increased Destruction (Hemolytic Anemias) Intrinsic (Intracorpuscular) Abnormalities Hereditary Membrane abnormalities (e.g., hereditary spherocytosis) Enzyme deficiencies (e.g., glucose-6-phosphate dehydrogenase) Disorders of hemoglobin synthesis Structurally abnormal globin synthesis (hemoglobinopathies): sickle cell anemia Deficient globin synthesis: thalassemia syndromes Acquired Membrane defect: paroxysmal nocturnal hemoglobinuria (rare) Extrinsic (Extracorpuscular) Abnormalities Antibody-mediated Nonautoantibodies: transfusion reactions, hemolytic disease of the fetus and newborn Autoantibodies Mechanical trauma to red cells Microangiopathic hemolytic anemias (e.g., disseminated intravascular coagulation) Defective cardiac valves Infections: malaria Impaired Red Cell Production Disturbed proliferation and differentiation of stem cells: aplastic anemia Disturbed proliferation and maturation of erythroblasts Defective DNA synthesis: vitamin B and folic acid deficiency (megaloblastic anemias) 12 Anemia of renal failure (erythropoietin deficiency) Anemia of chronic inflammation (iron sequestration, relative erythropoietin deficiency) Marrow replacement: primary hematopoietic neoplasms (acute leukemia, myelodysplastic syndromes) Marrow infiltration (myelophthisic anemia): metastatic neoplasms, granulomatous disease Table 9.2 Microcytic, Normocytic, and Macrocytic Anemias Microcytic Anemia (Causes and Characteristic Laboratory Findings) Iron deficiency Low serum iron, low serum ferritin, high serum transferrin Thalassemia High serum iron, high serum ferritin, normal serum transferrin Normocytic Anemia (Causes and Characteristic Findings) Anemia of chronic inflammation Elevated red cell sedimentation rate, low serum iron, high serum ferritin, normal or low serum transferrin Anemia of renal failure Elevated creatinine and blood urea nitrogen Hereditary spherocytosis Evidence of hemolysis, spherocytic red cells Immunohemolytic anemia Evidence of hemolysis, spherocytic red cells, direct Coombs test positive Mechanical destruction of red cells Evidence of hemolysis, red cell fragments (schistocytes) in peripheral blood Sickle cell anemia Evidence of hemolysis, sickled red cells in peripheral blood Anemia of marrow infiltration Teardrop-shaped red cells, nucleated red cells, early white cell progenitors in periph- eral blood (leukoerythrocytosis) Malaria, babesiosis Evidence of hemolysis, organisms seen within red cells G6PD deficiency Evidence of hemolysis, red cells with “bites” Macrocytic Anemia (Causes and Characteristic Laboratory Findings) Folate, Vitamin B deficiency Macroovalocytic red cells, hypersegmented neutrophils, megaloblastic marrow 12 progenitors Myelodysplastic syndromes Dysplastic marrow progenitors and peripheral blood elements Aplastic anemia Pancytopenia Liver disease, alcoholism Target red cells in peripheral blood smears CHAPTER 9 Hematopoietic and Lymphoid Systems 139    Hemosdernura and oss of ron. Hemogobn absorbed by rena  rom  e spl e n  c ve nous c  rc u l a  on , re su l  ng n e x  r av as c u l ar ubuar ces s processed no emosdern and os wen rena ces e moly s s. Spl e ne c omy  mprove s  e ane m  a , bu no  e u nd e rly - soug no e urne.  ng ge ne   c d e e c  , e nc e spe ro c y e s re ma n n  e bl o o d. Laboraory ndngs sared by nravascular and exravascular emo- lyc anemas nclude retcuocytoss (ncreased mmaure red cells, called Clncal Features. he dagnoss depends on e amy sor y, e reculocyes, n e perperal blood), eevated serum actate deydro- evdence o exravascuar emoyss, e presence o sperocyes n genase (an enzyme released rom lysed red cells), and decreased serum perpera smears, and oer ess. Foowng spenecomy, paens eves of aptogobn (a plasma proen a bnds ree emoglobn). ave an exceen prognoss bu are a rsk or sepss w encapsuaed Hemolyc anemas are less common an underproducon ane- bacera due o e oss o spenc uncon. hey aso are prone o apas- mas (dscussed laer), bu several are o paogenc neres and mer c crses durng necons by par vovrus B19, wc necs and ks consderaon. er yrod progenors n e marrow. hs necon s rapdy ceared by e mmune sysem and as no consequences n norma ndvduas, Hereditary Spherocytosis bu  eads o rapdy worsenng anema n HS and oer emoyc Hereditary spherocytosis is caused by inherited defects in red cell anema paens n wom e red ce a-e s markedy decreased. membrane skeleton proteins that lead to membrane loss and the Sickle Cell Anemia formation of spherocytes that lose deformability. Sickle cell anemia, a prototypical hemoglobinopathy, is an autoso- Pathog e ne s s. T e  n e r  anc e o e re d  ar y spe ro c y o s  s (HS) s mal recessive disorder caused by a single amino acid substitution usu a l ly auo s oma l d om  n an. In p e r pe r a l bl o o d s me ars , spe ro - in β-globin that creates sickle hemoglobin. c y e s l a ck c e n r a l p a l l or (F  g. 9. 1). T e c el ls c an no p ass   rou g  Scke ce anema s e mos common ama emoyc anema. In  e nar row sl  - l  ke op e n  ng s  a s e p ar ae  e spl e n  c re d pu lp pars o Arca, e gene requency approaces 30%, appareny because o a proecve efec o sckle emoglobn (HbS) agans malara n eerozy- goes. In e Uned Saes, approxmaely 8% o paens o Arcan descen are eerozygous HbS carrers and abou 1 n 600 as sckle cell anema. Pathogeness. Sckle cell anema s caused by a muaon n -globn a leads o e polymerzaon o sckle emoglobn (HbS) no long, sf cans wen  s deoxygenaed. As a resul, e cell assumes an elongaed sckle sape bu  reurns o s normal sape wen oxygen- aed (Fg. 9.2). he mos mporan varabe a deermnes weer HbS-conanng red ces undergo sckng s e nraceuar concen- raon o oer emogobns. In eerozygoes, approxmaey 60% o emogobn s norma HbA, wc neracs ony weaky w deoxy- genaed HbS and reards HbS poymerzaon; as a resu, eerozygoes w HbS are generay asympomac (ey are sad o ave e scke ce ra). Fea emogobn (HbF) aso neracs weaky w HbS; s expans wy newborns w scke ce anema are asympomac un e HbF eves a a 5 o 6 mons o age. Fig. 9.1 Hereditary spherocytosis: peripheral blood smear. Note the Sckng o red ces n paens w scke ce anema as wo major anisocytosis and several hyperchromic spherocytes. Howell-Jolly bod- consequences: (1) cronc emoyc anema and (2) epsodc pan cr- ies (small nuclear remnants) are also present in the red cells of this ses assocaed w scemc ssue damage (Fg. 9.3). Hemoyss sems asplenic patient. (Courtesy of Dr. Robert W. McKenna, Department of rom repeaed sckng, wc damages e red ce membrane, evenuay Pathology, University of Texas Southwestern Medical School, Dallas.) A B Fig. 9.2 Sickle cell anemia: peripheral blood smear. (A) Low magnification shows sickle cells, anisocytosis, poi- kilocytosis, and target cells. (B) Higher magnification shows an irreversibly sickled cell in the center. (Courtesy of Dr. Robert W. McKenna, Department of Pathology, University of Texas Southwestern Medical School, Dallas.) 140 CHAPTER 9 Hematopoietic and Lymphoid Systems condon. Adu emogobn, or HbA, s a eramer composed o wo α cans and wo  cans. he α cans are encoded by wo α-gobn G G A T genes yng n andem on cromosome 16, wereas e  cans are Point C C G G encoded by a snge -gobn gene ocaed on cromosome 11. Muc T mutation A o e varaon n α- and -aassemas s due o e nerance o C C dferen combnaons o muaed alleles (Table 9.3).    β-aassema. here are wo ypes o aees, dsngused by dferen 0 sngle-base muaons: (1)  alleles, wc produce no -globn and HbA HbS + (2)  alleles, wc produce reduced amouns o -globn. Persons nerng one abnormal allele ave -alassema mnor (also known 0 + as -alassema ra). Mos people nerng any wo  and  alleles RBC ave -alassema major, bu occasonally persons nerng a leas + one  allele ave a mlder dsease ermed -alassema nermeda. Deoxygenation he deecve syness o -gobn conrbues o anema n Irreversibly wo ways: (1) e nadequae ormaon o HbA resus n mcro- sickled 2+ + cell cyc, poory emogobnzed red ces and (2) e excess unpared Ca K , H O 2 α-gobn cans orm oxc precpaes a damage e membranes Hemolysis o er yrod precursors, mos o wc de by apoposs (Fg. 9.4) Extensive (nefecve er yropoess). he red ces a are produced ave membrane damage membrane damage, eadng o emoyss. Facors reeased rom Oxygenation er yrod progenors ndrecy ncrease e absorpon o dear y ron, eadng o ron overoad (dscussed aer). Additional Reversibly cycles of    α-aassema. α-haassema s caused by deeon o one or more o sickled Deoxygenation, deoxygenation e α-gobn genes; dsease severy s proporona o e number o cell prolonged α-gobn genes a are deeed (see Tabe 9.3). Excess -gobn and transit times Microvascular γ-gobn cans orm reavey sabe  and γ eramers known as 4 4 occlusion HbH and Hb Bars, respecvey, wc cause ess membrane damage Cell with dehydration an ree α-gobn cans. Inefecve eryropoess and emolyss and membrane damage are less pronounced n HbH dsease an n -alassema. However, Fig. 9.3 Pathophysiology of sickle cell disease. HbA, hemoglobin A; bo HbH and Hb Bars delver oxygen neiceny o ssues. HbS, sickled hemoglobin; RBC, red blood cell. Morphology. In -aassema mnor and α-aassema ra, producng rreversby scked ces a are rapdy removed rom e cr- abnormaes are conned o e perperal blood. Red cells are small cuaon. Pan crses are caused by ocazed obsrucon o e mcrovas- (mcrocyc) and pale (ypocromc) bu normal n sape. -alassema cuaure by scked red ces. hese obsrucons are argey conned o major red cells sow marked mcrocyoss, ypocroma, ansocyoss ssues n wc blood low s suggs, suc as e speen, e marrow, (varaon n cell sze), and pokocyoss (varaon n cell sape). and nlamed ssues, were e rans me o red ces roug capar- Nucleaed red cells (normoblass) also are seen n e perperal blood. es exceeds e me requred or sckng o ces oowng deoxygenaon. -haassema nermeda and HbH dsease sow eaures beween ese wo exremes. In -aassema major, yperpasc eryrod Clncal Features. In scke ce dsease, rreversby scked ces can be progenors ll e marrow, nvade e bony corex, mpar bone grow, seen n perpera bood smears. In eerozygoes, sckng s nduced and produce skeleal deormes. Exrameduary emaopoess resuls nvro by exposng ces o ypoxc condons. he presence o HbS s n promnen splenomegaly, epaomegaly, and lympadenopay. conrmed by emoglobn elecroporess. HbH dsease and -alassema nermeda are assocaed w a lesser Obsrucon o blood low n e speen eads o spenc auonarc- degree o splenomegaly, eryrod yperplasa, and grow reardaon. on, markedy ncreasng e rsk or sepss w encapsuaed bacera. Addona compcaons ncude e-reaenng sckng crses o e Clncal Features. he dagnoss s based on e amy sor y, perp- ung (acue ces syndrome) oowng pumonar y necons; sroke; era bood ndngs, and laboraor y ess. Hemoglobn elecroporess and rena damage a may ead o bndness. Hydroxyurea rases can deec abnormal emoglobns suc as HbH, as well as HbA , a 2 HbF eves and as annlammaor y efecs, bo o wc decrease mnor emoglobn a s oten ncreased n -aassema Cnca e ncdence o pan crses. eaures var y wdey : Thalassemias    β-aassema ra and α-aassema ra paens are ypcay Thalassemias are inherited disorders caused by mutations in glo- asympomac and ave md mcrocyc anema. bin genes that result in decreased synthesis of α- or β-globin. The    β-aassema major maness posnaay wen HbF syness dmn- associated anemia results from reduced hemoglobin synthesis and ses. Increased numbers o red ce precursors consume nurens, hemolysis due to an imbalance in globin chain synthesis. causng grow reardaon and cacexa. Survva no aduood s haassema s common n Mederranean, Arcan, and Asan regons possbe w ransusons and reamen w an ron ceaor, wc n wc maara s endemc; e assocaed muaons may proec prevens ron overoad and assocaed cardac dysuncon. Hemaopo- agans acparum maara. ec sem ce ranspanaon a an eary age s e reamen o coce.    HbH dsease and β-aassema nermeda are no as severe as Pathogeness. A dverse coecon o α-gobn and -gobn muaons -aassema major. Anema s moderae and paens usuay do causes severe orms o aassema, wc s an auosoma codomnan no requre ransusons. CHAPTER 9 Hematopoietic and Lymphoid Systems 141 Table 9.3 Clinical and Genetic Classification of Thalassemias Clinical Syndrome Genotype Clinical Features Molecular Genetics -Thalassemias -Thalassemia major Homozygous -thalassemia Severe anemia; regular blood transfusions Mainly point mutations that lead 0 0 + + 0 + ( / ,  / ,  / ) required to defects in the transcription, 0 + + + 0 + splicing, or translation of -glo- -Thalassemia inter- Variable ( / ,  / ,  /,  /) Severe anemia, but regular blood transfusions bin mRNA media not required -Thalassemia minor Heterozygous -thalassemia Asymptomatic with mild or absent anemia; 0 + ( /,  /) red cell abnormalities seen α-Thalassemias Silent carrier −/ α, α/α Asymptomatic; no red cell abnormality Mainly gene deletions α-Thalassemia trait −/−, α/α (Asian) Asymptomatic, like -thalassemia minor −/α, −/α (black African, Asian) HbH disease −/−, −/ α Severe; resembles -thalassemia intermedia Hydrops fetalis −/−, −/− Lethal in utero without transfusions HbH, hemoglobin H; mRNA, messenger ribonucleic acid. NORMAL β-THALASSEMIA Reduced β-globin synthesis, Insoluble α-globin aggregate with relative excess of α-globin HbA (α β ) 2 2 HbA Normal erythroblast Abnormal erythroblast α-globin Few abnormal aggregate red cells leave Normal HbA Hypochromic red cell Normal red blood cells Ineffective erythropoiesis Most erythroblasts Extravascular hemolysis die in bone marrow Destruction of aggregate-containing Dietary iron red cells in spleen ANEMIA Increased iron Blood absorption transfusions Tissue hypoxia Reduce Erythropoietin increase Liver Heart Marrow expansion Systemic iron overload (secondary hemochromatosis) Skeletal deformities Fig. 9.4 Pathogenesis of -thalassemia major. Note that aggregates of excess α-globin are not visible on routine blood smears. Blood transfusions constitute a double-edged sword, diminishing the anemia and its attendant complications but also adding to the systemic iron overload. HbA, hemoglobin A. 142 CHAPTER 9 Hematopoietic and Lymphoid Systems Glucose-6-Phosphate Dehydrogenase (G6PD) Deficiency anbodes a cross e pacena and cause emoyss o ea red ces. Mos Mutations that cause G6PD deciency decrease the half-life of G6PD cases o emoyc dsease o e eus and newborn occur n pregnances protein, leaving older red cells at risk for oxidant damage and n wc e eus expresses RD angen and e moer s RD angen intravascular hemolysis. negave, or n wc ere s ABO angen ncompaby beween e eus G6PD decency s an X-lnked dsorder a afecs approxmaely and e moer. Generay, e rs angen-ncompable pregnancy does 10% o black males n e Uned Saes. G6PD s an enzyme needed or no produce dsease because e moer does no produce an–red cell IgG e syness o reduced gluaone (GSH), wc parcpaes n e elm- anbodes (e ype a crosses e placena) beore delvery. he rsk rses naon o poenally njurous reacve oxygen speces. he enzyme de- w eac subsequen ncompabe pregnancy owng o memory B ces a cency resuls n cell damage caused by exposure o ree radcals. All cells respond rapdy wen ey are reexposed o angen. IgG-medaed yss o n e body express muaed G6PD, bu e dsorder maness only n red ea red ces eads o progressve anema, ssue scema, nrauerne car- cells because ey lack e capacy o synesze new proens. hus, e dac aure, and perpera edema, and may be aa n severe cases. agng red ces o afeced paens become severely G6PD decen and are R-negave moers are reaed w R mmune gobun parcularly suscepble o oxdan-nduced damage and lyss. (RIg) a 28 weeks and wn 72 ours ater dever y o an R-pos- Hemolyss n G6PD decenc y s epsodc and ollows exposures ve baby. e RIg masks e angenc ses on e ea red ces and a ncrease e producon o oxdans, parcularly acue necons prevens senszaon o R angens. As a resu, AB O ncompaby and exposure o ceran drugs. A caracersc ndng n perperal s now e mos common cause o emoyc dsease o e eus and smears s “be” cells, red cells w severely damaged membranes newborn. ABO ncompaby occurs n approxmaey 20% o 25% a ave porons “ben of ” by macropages removng paces o o pregnances, bu emoyss deveops n ony a sma racon o sub- membrane w assocaed emoglobn precpaes known as Henz sequen pregnances, prmary n ceran group O women wo make bodes, leadng o nravascular emolyss (Supplemenal eFg. 9.1). IgG anbodes dreced agans group A or B angens (or bo) a he emoyss s oten ransen, even w perssen necon or cross e pacena and reac e ea crcuaon. In genera, e dsease drug exposure, because yss o oder ces eaves younger ces w s muc mder an R ncompaby, n par because many ces ger eves o G6PD a are ressan o oxdan sress. oer an red ces express A and B angens and us adsorb some o e ranserred anbodes. ere s no efecve meod o prevenng emolyc dsease resulng rom AB O ncompably. Immunohemolytic Anemia Immunohemolytic anemia is caused by antibodies that bind to Mechanical Trauma to Red Cells antigens found on red cell membranes. e paogenc anbodes may arse sponaneousy or be nduced Inravascular emolyss o red cells due o er exposure o abnormal by exogenous agens suc as drugs or cemcas. Immunoemoyc mecancal orces occurs n wo sengs. anema s cassed on e bass o (1) e naure o e anbody and    Traumatc emoyss due o deecve cardac valve proseses, (2) e presence o predsposng condons (summarzed n Table 9.4). wc may sear red cells (e blender efec), or an acvy resul- hus, e anema may be prmary (dopac) or secondary o oer ds- ng n repeaed pyscal poundng o one or more body pars (e.g., orders o e mmune sysem. In mos nsances, e bound anbodes maraon racng, bongo drummng, karae). ac as opsonns and e emoyss s exravascuar. he drec Coombs    Mcroangopatc emoytc anema occurs wen small vessels es deecs anbodes and/or compemen on red ces and s ereore become narrowed by romb. Mos requenly, s s due o ds- posve. Dependng on e cause and e severy o e emoyss, rea- semnaed nravascular coagulaon (DIC) (descrbed laer), n men may nvove mmunosuppresson, remova o suspeced rggers, or wc vessels are narrowed by e nravascular deposon o brn, reamen o underyng condons. and romboc rombocyopenc purpura and emolyc-uremc syndrome, n wc vessels are narrowed by plaele-rc romb. Hemolytic Disease of the Fetus and Newborn he cnca sgncance o mcroangopac emolyss s a  This disorder results from an antibody-induced hemolytic anemia oten ndcaes a serous underyng condon. caused by blood group incompatibility between the mother and Mecancay ragmened red ces (scsocyes) are easy recog- the fetus. nzed n perpera bood smears, were ey ake on e appearance o burr ces, eme ces, and range ces (Fg. 9.5). Pathogeness. Red ce ncompaby occurs wen e eus ners red Malaria ce angenc deermnans rom e aer a are oregn o e moer. Fea red ces oten ener e maerna crcuaon durng e as rmeser o It is estimated that malaria affects 500 million and kills more than pregnancy or durng cdbr (eomaerna beed), senszng e moer 400,000 people per year, making it one of the most widespread o paerna red ce angens and eadng o e producon o an–red ce afictions of humans. Maara s ransmed by e be o Anopees mosquoes and s Table 9.4 Classification of Immunohemolytic Anemias endemc n Asa and Arca; due o wdespread je rave, cases are seen wordwde. O e ve causave Pasmodum speces, Pasmodum fa- o Warm Antibody Type (active at 37 C) cparum s e mos mporan because  causes a serous dsorder w Primary (idiopathic) a g aaly rae. Secondary : B-cell neoplasms (e.g., chronic lymphocytic leukemia), autoimmune disorders (e.g., systemic lupus erythematosus), Pathogeness. Wen mosquoes eed on umans, sporozoe orms are drugs (e.g., α-methyldopa, penicillin, quinidine) nroduced a nec lver cells, were ey mulply as merozoes and Cold Antibody Type (active at temperatures lower than core are en released o nec red cells (Fg. 9.6). Inraer yrocyc para- body temperature) ses eer connue asexual reproducon as ropozoes or gve rse Acute: Mycoplasma infection, infectious mononucleosis o gameocyes a are capable o necng e nex ungr y mosquo. Chronic: idiopathic, B-cell lymphoid neoplasms (e.g., lymphoplasma- he asexua pase s compee wen e ropozoes gve rse o new cytic lymphoma) merozoes, wc escape by ysng e red ces.

Use Quizgecko on...
Browser
Browser